Tower Research Capital (TRC)’s Tonix Pharmaceuticals TNXP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $258K | Buy |
7,172
+3,731
| +108% | +$134K | 0.01% | 1554 |
|
|
2025
Q1 | $61.5K | Buy |
+3,441
| New | +$61.5K | ﹤0.01% | 2083 |
|
|
2024
Q4 | – | Sell |
-356
| Closed | -$5.31K | – | 6005 |
|
|
2024
Q3 | $5.31K | Buy |
356
+306
| +612% | +$4.56K | ﹤0.01% | 4293 |
|
|
2024
Q2 | $3.51K | Buy |
50
+39
| +355% | +$2.74K | ﹤0.01% | 4879 |
|
|
2024
Q1 | $6.4K | Buy |
+11
| New | +$6.4K | ﹤0.01% | 4378 |
|
|
2022
Q4 | – | Sell |
-1
| Closed | -$6K | – | 6378 |
|
|
2022
Q3 | $6K | Buy |
+1
| New | +$6K | ﹤0.01% | 5058 |
|
|
2022
Q2 | – | Hold |
0
| – | -$18K | – | 4313 |
|
|
2022
Q1 | – | Hold |
0
| – | -$10K | – | 3647 |
|
|
2021
Q4 | – | Hold |
0
| – | -$7K | – | 4611 |
|
|
2021
Q3 | – | Hold |
0
| – | -$27K | – | 4675 |
|
|
2021
Q2 | – | Hold |
0
| – | -$9K | – | 3611 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 4435 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 4294 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 4274 |
|
|
2017
Q2 | – | Hold |
0
| – | -$11K | – | 3535 |
|
|
2017
Q1 | – | Hold |
0
| – | – | – | 1718 |
|
|
2016
Q3 | – | Hold |
0
| – | -$1K | – | 4445 |
|
|
2016
Q2 | – | Hold |
0
| – | -$7K | – | 4218 |
|
|
2016
Q1 | – | Hold |
0
| – | – | – | 2410 |
|
|
2015
Q3 | – | Hold |
0
| – | -$3K | – | 4810 |
|
|
2015
Q2 | – | Hold |
0
| – | -$2K | – | 3585 |
|
|
2015
Q1 | – | Hold |
0
| – | -$3K | – | 3827 |
|
|
2014
Q4 | – | Hold |
0
| – | -$1K | – | 3161 |
|
|
2014
Q3 | – | Hold |
0
| – | -$1K | – | 4158 |
|
|
2014
Q2 | – | Hold |
0
| – | -$2K | – | 3760 |
|
|
2014
Q1 | – | Hold |
0
| – | -$14K | – | 3913 |
|
|
2013
Q4 | – | Hold |
0
| – | -$3K | – | 2686 |
|
|
2013
Q3 | – | Hold |
0
| – | – | – | 3971 |
|